Federal award
SIEMENS HEALTHCARE DIAGNOSTICS INC.
W81K0021P0002
Contract
Obligated and Ceiling
- Obligated (net)
- $124,940.71
- Ceiling (potential value, not spending)
- $124,940.71
- Current value
- $124,940.71
- Gross positive obligations
- $124,940.71
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SIEMENS HEALTHCARE DIAGNOSTICS INC. · GC14SNHB3JN1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ALTAIR ENGINEERING INC. · XEAUKVYXD3W1
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0021P0002
- Award type code
- B
- Actions
- 9 · Oct 21, 2020 to Nov 14, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Nov 14, 2024 | FY2025 | P00008 | C | $24,940.71 | — |
| Jan 25, 2024 | FY2024 | P00007 | G | $0.00 | — |
| Nov 1, 2023 | FY2024 | P00006 | C | $25,000.00 | — |
| Aug 15, 2023 | FY2023 | P00005 | G | $0.00 | — |
| Oct 12, 2022 | FY2023 | P00004 | C | $25,000.00 | — |
| Aug 11, 2022 | FY2022 | P00003 | G | $0.00 | — |
| Oct 14, 2021 | FY2022 | P00002 | C | $25,000.00 | — |
| Jun 9, 2021 | FY2021 | P00001 | G | $0.00 | — |
| Oct 21, 2020 | FY2021 | 0 | — | $25,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.